跳至主要内容
临床试验/NCT00288743
NCT00288743已完成2 期

Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study

University Hospital, Ghent1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2002年9月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
30
试验地点
1
主要终点
To evaluate compliance, efficacy and safety of an insulin protocol, with target glycemia between 81-110 mg/dL in critically ill patients

研究概览

简要总结

There is a growing body of evidence in the literature regarding the adverse effects of hyperglycemia in critically ill patients. To target and maintain better blood glucose regulation we implemented an insulin protocol with target blood glucose levels between 81-110 mg/dL.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Surgical or medical critically ill patients
  • •An expected ICU-stay of more than 72 hours
  • •Age > 16 years
  • •Need for insulin therapy
  • •Patients must have an arterial line

排除标准

  • •Patients who did not respond to the inclusion criteria
  • •Patients with diabetic ketoacidosis
  • •Cardiac surgical patients
  • •Patients transferred from other hospitals
  • •Other study enrollment

结局指标

主要结局

To evaluate compliance, efficacy and safety of an insulin protocol, with target glycemia between 81-110 mg/dL in critically ill patients

次要结局

  • To determine potential factors associated with blood glucose control

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Adherence, Efficacy and Safety of an Insulin... | 临床试验